Authors: Geerlings, SE Stolk, RP Camps, MJL Netten, PM Collet, JT Schneeberger, PM Hoepelman, AIM

Citation: Se. Geerlings et al., Consequences of asymptomatic bacteriuria in women with diabetes mellitus, ARCH IN MED, 161(11), 2001, pp. 1421-1427

Authors: de Boer, WA Van Etten, RJXM Van de Wouw, BAM Schneeberger, PM Van Oijen, AHAM Jansen, JBMJ

Citation: Wa. De Boer et al., Bismuth-based quadruple therapy for Helicobacter pylori - a single triple capsule plus lansoprazole, ALIM PHARM, 14(1), 2000, pp. 85-89

Authors: Schneeberger, PM Keur, I van Loon, AM Mortier, D Op de Coul, K Verschuuren-Van Haperen, A Sanna, R van der Heijden, TG van den Hoven, H van Hamersvelt, HW Quint, W van Doorn, LJ

Citation: Pm. Schneeberger et al., The prevalence and incidence of hepatitis C virus infections among dialysis patients in The Netherlands: A nationwide prospective study, J INFEC DIS, 182(5), 2000, pp. 1291-1299

Authors: van Doorn, LJ Schneeberger, PM Nouhan, N Plaisier, AP Quint, WGV de Boer, WA

Citation: Lj. Van Doorn et al., Importance of Helicobacter pylori cagA and vacA status for the efficacy ofantibiotic treatment, GUT, 46(3), 2000, pp. 321-326

Authors: de Boer, WA van Etten, RJXM Schneeberger, PM Tytgat, GNJ

Citation: Wa. De Boer et al., A single drug for Helicobacter pylori infection: First results with a new bismuth triple monocapsule, AM J GASTRO, 95(3), 2000, pp. 641-645

Authors: Schneeberger, PM Toonen, N Keur, I van Hamersvelt, HW

Citation: Pm. Schneeberger et al., Infection control of hepatitis C in Dutch dialysis centres, NEPH DIAL T, 13(12), 1998, pp. 3037-3040